The patent EP3845537B1 was granted to Taiho Pharmaceutical on Jul 30, 2025 following the initial filing on Aug 28, 2019 under the application number EP19855702A . The current legal status of the patent is Granted And Under Opposition.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents